Join the InvestorsHub Community

https://www.otcmarkets.com/stock/NOUV

Good luck with that one, they have pretty much been a dead horse...Hey, but you never know...Like I said, good luck with that one...

Interestingly enough. I happen to own the domain name Nouvai*com

Perhaps this company might be interested in acquiring the name from me when I put it up for sale.

TRADE DATA
DATE TIMESTAMP PRICE VOLUME
08/28/2023 14:30:52
0.0002
500,000
08/28/2023 14:30:19
0.0002
500,000
08/28/2023 14:29:59
0.0002
500,000
08/28/2023 14:18:25
0.0002
500,000
08/28/2023 14:17:44
0.0002
500,000
08/28/2023 14:16:46
0.0002
500,000
08/28/2023 14:15:48
0.0002
500,000
08/28/2023 13:25:17
0.0002
515,000
08/24/2023 11:30:15
0.0002
5,678
08/24/2023 11:29:54
0.00015
5,555

NOUV
Nouveau Life Pharmaceuticals Inc (PK)
0.0002
0.00 (0.00%)
Volume: 30,238,723
Day Range: 0.0001 - 0.0002
Last Trade Time: 2:25:47 PM EDT

TRADE DATA
DATE TIMESTAMP PRICE VOLUME
08/11/2023 14:25:47
0.0002
11,111
08/11/2023 14:10:10
0.0001
600,000
08/11/2023 13:23:33
0.0002
515,000
08/11/2023 13:09:02
0.0002
11,111
08/11/2023 12:48:01
0.00015
1,500
08/11/2023 10:43:10
0.0001
8,028,923
08/11/2023 10:43:10
0.0001
10,000,000
08/11/2023 10:43:10
0.0001
1,000,000
08/11/2023 10:43:10
0.0001
2,000,000
08/11/2023 10:43:10
0.0001
2,000,000

NOUV
Nouveau Life Pharmaceuticals Inc (PK)
0.0002
0.00 (0.00%)
Volume: 425,781
Day Range: 0.0001 - 0.00021
Last Trade Time: 2:33:15 PM EDT

NOUV
Nouveau Life Pharmaceuticals Inc (PK)
0.00025
0.00005 (25.00%)
Volume: 200,000
Day Range: 0.00025 - 0.00025
Last Trade Time: 1:37:18 PM EDT

Amended fillings and disclosure...06/13/2023


https://www.otcmarkets.com/stock/NOUV/overview

Be very careful of Frankie baby, he's known to have very little to no follow through on any of his tickers. All of his tickers are in the dumps & nouv looks like it has it's on special corner in the dumpster. Frank has no success stories. Buyer beware

Honestly, I hope you're right, I have a boatload of shares here...It's just that the CEO hasn't ever posted a single bit of news in the year and a half since he took this ticker over...Like I said, I hope you're right...

Well, something is going on. They filed a quarterly report on 5/20 for quarter ending 3/31. (It says they are losing less money, if I am reading it correctly.)

Good luck with that one...I'd like nothing more than for that to be true, but this thing seems pretty much dead...Call this number from SeniorGo's website and you'll see what I mean...


2390 El Camino Real,
Palo Alto, CA 94306,
United States

Call 888 699 7823
Email: young@seniorgo.ai

SeniorGo Service

Ready to start climbing again.

For a company that bought this ticker about a year and a half ago, I'd say they haven't done sh*t to make a go of it... Investor Relations, what a joke...

Nouveau Life Pharmaceuticals, Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

For the Period Ended

March 31, 2023 December 31, 2022

Ordinary Income/Expense

Expense

Advertising and Promotion

107

964.00

Automobile & Travel Expenses

160

1,436.90

Business Licenses and Permits: NV SOS

217

652.00

Bus. Licenses & Permits-Other

7,140

35,700.00

Community Outreach

388

1,165.00

Computer and Internet Expenses

188

562.97

Insurance Expense

128

385.00

Office Supplies

453

1,358.00

Professional Fees

39

352.00

Accounting

232

2,085.00

Business Development

255

2.295.00

Investor Relations

161

1,450.00

Legal

1,250

11,250.00

OTC Markets

3,660

7,429:00

Stock Transfer Agents

667

6,000.00

Rent & Lease Expense

486

4,373.29

Telephone Expense

459.70

Training and Staff Development

205

1,845.00 79,762.86

Total Expense

15,787

Net Ordinary Income

(15.787)
March 31, 2023
(79,762.86)

BASIC AND DILUTED LOSS PER SHARE:

($0.000002)

($0.00001)

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: Basic

6,660,963,733

6,660,963,733

The accompanying notes are an integral part of these financial statements.

I'm actually surprised he's doing anything to save this ticker, he sure doesn't seem to give a sh*t about it or it's investors...

NOTIFICATION OF LATE FILING

Name of the Issuer:

Annual Report

For Period Ended March 31, 2023

Nouveau Life Pharmaceuticals, Inc.

Check One:

X Quarterly Report Interim Report

Address of Principal Executive Office:

3580 Wilshire Blvd, Suite 100

Los Angeles, CA 90010

Reason for Delay in Posting Financial Report State below in reasonable detail why the Annual/Quarterly Report could not be filed within the prescribed time period

prepare the quarterly financial statements and quarterly report

The Quarterly Report cannot be filed within the prescribed date because the issuer requires additional time to

Anticipated Filing Date: 5/22/2023

Person to contact regarding this notification: Date: 05/15/2023

Officer/Director Signature: Date: 05/15/2023

Instructions to post Notification of Late Filing in www.OTCIQ.com

1. Fill out this Notification of Late Fing form and convert the file to a PDF

2. Log in to www.OTCIQ.com and click "Add Financial Report" on the left hand navigation

3. Select Dissemination Date "Immediate 4. Under Report Type, select "Notification of Late Filing

Signature is Sang The Cho Name: Sang Tae Chal Title: CEO Signature /s/ Sang Tee Choi Name: Sang Tae Choi Title: GEO 5. Enter Period End Date corresponding to the quartentiscal year end date for which this Notice is being filed 6. Click "Browse" and select the PDF saved in step 1 above. 7. A preview of the document will appear next. Please make sure to review the entire document & scroll down to click the "Submit" button. Your Notification of Late Filing will appear within a few minutes on otomarkets.com Alterative Reporting companies on the Pink Current tier may utilize the Notification of Late Filing to receive the extension. The Notification must be submitted by the applicable reporting deadline to qualify for the OTCQB and OTCQX non-SEC reporting companies may also post this document to remain compliant with OTC reporting requirements Conditional Fang Relief for Companies Affected by the Coronavin: Issuer must specifically disclose a summary of why relief is needed in the Notification of Late Filing in order to receive the 45 day extension

https://www.otcmarkets.com/otcapi/company/financial-report/370899/content

NOUV
Nouveau Life Pharmaceuticals Inc (PK)
0.0002
0.00 (0.00%)
Volume: 225,959
Day Range: 0.0002 - 0.0003
Last Trade Time: 3:22:38 PM EDT

They Financials are crazy these jokas outright said we cash strapped & may need to dilute SH. Smfh

Stock Promotion Tracking
Nouveau Life Pharmaceuticals, Inc. $NOUV – end of day report for April 20, 2023

on April 20, 2023
End of Day Reports
and Tags: NOUV, Nouveau Life Pharmaceuticals Inc.
with 0 comments
Nouveau Life Pharmaceuticals, Inc.
Market capitalization:
$1,998,289
(as of April 17, 2023)
Floating shares:
6,101,314,475
(as of March 24, 2023)
Outstanding shares:
6,660,963,733
(as of April 17, 2023)
Authorized shares:
11,000,000,000
(as of April 17, 2023)
NEW FEATURE: We now report on potential upcoming stock promotions.
Learn about these new reports here and then click to view the reports here!
Last 11 Closing Quotes For NOUV
Date Open Close Change High Low Share Volume
April 20, 2023 0.0002 0.0003 50% 0.0003 0.0002 34,129,600
April 19, 2023 0.0003 0.0002 -33% 0.0003 0.0002 2,957,600
April 18, 2023 0.0003 0.0003 0% 0.0003 0.0002 5,315,000
April 17, 2023 0.0003 0.0003 0% 0.0003 0.0002 997,700
April 14, 2023 0.0003 0.0003 0% 0.0003 0.0002 7,036,200
April 13, 2023 0.0003 0.0003 0% 0.0003 0.0002 755,000
April 12, 2023 0.0003 0.0003 0% 0.0003 0.0003 920,000
April 11, 2023 0.0003 0.0003 0% 0.0003 0.0002 1,015,300
April 10, 2023 0.0003 0.0003 0% 0.0003 0.0002 2,694,700
April 7, 2023 0.0002 0.0003 50% 0.0003 0.0002 49,137,000

Some pretty big trades so far today...


TRADE DATA
DATE TIMESTAMP PRICE VOLUME
04/20/2023 12:32:50
0.0003
1,000
04/20/2023 12:25:14
0.00021
10,000
04/20/2023 12:25:14
0.0002
4,990,000
04/20/2023 12:24:59
0.0002
8,925,000
04/20/2023 12:24:57
0.0002
75,000
04/20/2023 12:24:34
0.0002
1,951,651
04/20/2023 12:24:34
0.0002
4,973,349
04/20/2023 12:24:29
0.0002
75,000
04/20/2023 12:15:13
0.0002
10,000,000
04/20/2023 11:34:13
0.0002
100,000
Irregular/odd lot trades, which are not considered for the Open, High, Low or Closing prices, are not shown in trade data table.

NOUV
Nouveau Life Pharmaceuticals Inc (PK)
0.0003
0.00 (0.00%)
Volume: 7,036,209
Day Range: 0.0002 - 0.0003
Last Trade Time: 3:17:09 PM EDT

TRADE DATA
DATE TIMESTAMP PRICE VOLUME
04/14/2023 15:17:09
0.0003
11,111
04/14/2023 14:46:17
0.00025
5,000
04/14/2023 14:16:14
0.0003
999,999
04/14/2023 14:14:50
0.0003
999,999
04/14/2023 12:53:20
0.0002
1,000,000
04/14/2023 12:53:17
0.0002
1,000,000
04/14/2023 12:52:43
0.0002
1,000,000
04/14/2023 12:52:32
0.0002
1,000,000
04/14/2023 11:19:57
0.0002
310,000
04/14/2023 09:56:06
0.0003
710,000
Irregular/odd lot trades, which are not considered for the Open, High, Low or Closing prices, are not shown in trade data table

It looks like someone really wanted shares of NOUV, a big chunk of them went around the same exact time...I wonder if they know something...I hope so...
DATE TIMESTAMP PRICE VOLUME
04/06/2023 15:02:58
0.0003
5,000
04/06/2023 14:57:35
0.0002
1,439,473
04/06/2023 14:57:34
0.0002
10,000
04/06/2023 14:57:09
0.0002
1,928,111
04/06/2023 14:57:08
0.0002
10,000
04/06/2023 14:57:07
0.0002
257,500
04/06/2023 14:57:07
0.0002
26,804,389
04/06/2023 14:57:07
0.0002
825,000
04/06/2023 14:57:00
0.0002
175,000
04/06/2023 14:51:48
0.0003
111,373

49 million and change today on the volume...That was nice to see...

Pink Current

Filings & Disclosure:NOUV. (03/31/2023)
(vi) Counsel has considered the question as to whether the Issuer, including its
predecessors, is or ever was a “shell company” as stated in Rules 405 of the Securities Act of 1933 and 12b-2 of the Exchange Act of 1934 and have concluded that the Issuer is not now a “shell company” but was a shell company in the past. The Company currently
does not meet the definition of a shell corporation, as defined by Rule 405 of the
Securities Act of 1933 and Rule 12b-2 of the Securities Exchange Act of 1934.

https://www.otcmarkets.com/stock/NOUV/overview

I have no idea, just what they posted...I guess we sit back and wait... Nothing new there...But at least they are finally starting to do something other than sitting on their hands...

When does it list?

It is AI, NOUVAI, is their new ticker name...It's in my previous post...

It was signed, his signature just didn't show up when I copied it, legal reasons I guess...

Nouveau Life Pharmaceuticals, Inc.

SUPPLEMENTAL INFORMATION

MARCH 26, 2023

Nouveau Life Pharmaceuticals, Inc. (the "Company") was previously a shell company. The Company's status as a shell company has changed. Effective April 8, 2022, the Company ceased to be a shell company under the SEC's definition.

A shell company is defined as follows: Rule 12b-2 of the Securities Exchange Act of

1934 defines a shell company as a company that has

(A) no or nominal operations; and.

(B) either, (1) no or nominal assets; (2) assets consisting solely of cash and cash equivalents; or, (3) assets consisting of any amount of cash and cash equivalents and

nominal other assets.

The Company believes that it is no longer a shell company because on April 8, 2022 when the Company recommenced operation, more than fourteen years after it had abandoned its operation in 2008. On April 8, 2022, the company became the holding company for Seniorgo.ai and Seniorgo.ai was subsequently merged into NOUV to transform the business of the company and launch the new NOUVAI, with the goal of priving to Seniors, provides healthcare solution that realizes non-face-to-face care services. Since April 8, 2022, the Company has been engaging manufacturers and stakeholders in the industry both in the United States and South Korea to execute agreements with partners, customers, vendors, and manufacturers, reviewing licenses and sublicense agreements with potential licensors, interviewing and hiring employees, and conducting research and due diligence on potential partners, Joint-ventures, and acquisitions in the industry. The Company is also actively seeking additional acquisitions of other Senior health opportunities as time and resources permits. Many of these additional acquisitions are still at the early stage of due diligence or non-binding letter-of-intent to acquire.

Furthermore, the SEC, in Release No. 33-8869 (the "Release"), defines a "shell company" to mean a registrant, other than an asset-backed issuer, that has:

(A) No or nominal operations; and

(B) Either:

(1) No or nominal assets;

(2) Assets consisting solely of cash and cash equivalents; or
(3) Assets consisting of any amount of cash and cash equivalents and

nominal other assets; or This does not include a development stage company pursuing an actual business, a business combination related shell company, as defined in Rule 405, or an asset-backed issuer, as defined in Item 1101(b) of Regulation S-K [AB].

Subsequent to the revival of its Charter with the State of Nevada, the Company's business was reborn on July 21, 2021. The new management of the Company devoted the period between July 21, 2021 business reborn and April 8, 2022 business recommencement to solidify the new business plan for the Company. Since the relaunch of our business operations based on the merger with Seniorgo.ai on April 8, 2022, current management led by Mr Young Ju Kim has been executing on its new business plan for the Company by (a) interviewing and hiring employees, (b) evaluating trademarks, patents, and other intellectual properties, and (e) reviewing offers and proposal from potential targets and joint-venture partners.

We are considered a development stage company. Even in the event that we were not considered a development stage company, we would still not be considered a shell. The definition above uses the word "and" after (A) above, a company must have "no or nominal operations" before the analysis even gets to "no or nominal assets" and the other stems in (2). In other words, if a company can prove it has more than nominal operations, it cannot be considered a shell company as defined in the Release. The absence of immediate revenue does not in any way negate the company's position since most company in the early stages of development do not generate revenues upon start, but very later in their development stage.

In the Release, several comments were concerned that the definition of a shell company set forth above would capture virtually every company during its start-up phase and that the definition was therefore too broad. The SEC specifically addressed this situation in footnote 172 to the Release by saying, in applicable part:

Contrary to commenters' concerns, Rule 144(1)(1)(i) is not intended to capture a "startup

company," or in other words, a company with a limited operating history, in the

definition of a... shell company, as we believe that such a company does not meet the

condition of having "no or nominal operations."

One can do an analysis of a startup company's business activities during its "limited operating history" to determine whether the company has engaged in activities that are, at a minimum, sufficient to manifest a strong commitment to developing a legitimate

business. These activities include, but are not limited to, the following:

1. entering into agreements with customers, vendors, manufacturers, etc.;
2. filing patent, trademark, and copyright applications with respect to the company's intellectual property:

3. executing license or sublicense agreements with respect to the company's

intellectual property: 4. entering into product development agreements or similar agreements for the

development of a product or service. 5. hiring employees; and 6. incurring material operating expenses such as research and development,

We believe the Company is a development stage company pursuing an actual business as set forth in the Company's Business Plan.. The Company is pursuing contracts with multiple manufacturers and vendors, possible partnership, acquisition or joint-venture. We also believe that the Company does not meet the definition of a shell because we had and continue to have substantial operating activities since our business relaunch on April 8, 2022.

Certification

I. Young Ju Kim, hereby certifies the following: 1) I have reviewed this Supplemental Information Disclosure Statement of Nouveau

Life Pharmaceuticals, Inc.

2) Based on my knowledge, this Supplemental Information Disclosure Statement does not contain any untrue statement of a material fact or omit a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the information covered by this Supplemental Information Disclosure Statement

3) Based on my knowledge, the financial information included or incorporated by reference in this Supplemental Information Disclosure Statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this Supplemental Information Disclosure Statement.

DATED: March 26, 2023

Young Ju Kim'

Chairman and Principal Executive Officer

Lol from what? This ticker is dead thanks to merger frank put in here. Something about retirement services? At least pump what's new in today's world like AI and not senior care........

GOOD MORNING $NOUV!!!!!! EASY DOUBLE HERE WITHIN THE NEXT FEW DAYS!!!!!!

Nice!

And now, NOUV has gone Pink...

NOUV - Nouveau Life Pharmac... www.otcmarkets.com

Nouveau Life Pharmaceuticals, Inc.

Common Stock

0.0003 1

0.0001 50.00%

0.0002/0.0003 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 03/28/2023

Delayed (15 Min) Trade Data: 12:00am 03/28/2023

Pink

Pink Current Information

Verified Profile 03/2023

Transfer Agent Verified

Shell Risk

Overview

Quote

Company Profile

Se

OPEN

0.0003

VOLUME

9,553,500

DAILY

$NOUV, Verified Profile, has just been added, maybe this thing is finally waking up...

It might also have something to do with this...I mean it is almost March 31st...


Opportunity Zones Capital, LLC @opportunityzon · 3h @Alpharidge_Cap is constantly in communication with the new CEOs reminding them of the March 31, 2023 deadline that must be met by all OTC tickers, else... Many promised to kickstart their tickers. $PRDL $OCLG $NWTT $NOUV $ITRX $ILIM $CIVX $CDBT $CCWF $CAMG $ADCV $GYGC $icnm

yep, nice update. Getting things done.

They moved to, "Shell Risk", maybe that has something to do with it...

volume

NOUV
Nouveau Life Pharmaceuticals Inc (PK)
0.0002
0.0001 (100.00%)
Volume: 2,374,722
Day Range: 0.0001 - 0.0002
Last Trade Time: 3:56:38 PM EDT

Dam all of Frank's scams are bottoming out no coincidence Frank is no Caren C I think this guy is in over his head

NOUV
Nouveau Life Pharmaceuticals Inc (PK)
0.0002
0.00005 (33.33%)
Volume: 3,320,000
Day Range: 0.0001 - 0.0002
Last Trade Time: 12:58:39 PM EST

R/S CLAUSE...

Acquis Replying to @opportunityzon Sticking point: @Alpharidge_Cap wants to ensure that EXISTING SHAREHOLDERS ARE PROTECTED in all merger transactions. Thus, it intends to include a Restrictive Clause, forbidding Reverse-Splits for two years minimum after closing the deal, in all of its merger agreements.

Mick looks like this heading to the greys

So does the ticker revert back to Frankie if nothing comes of it by the date??

NOUV
Nouveau Life Pharmaceuticals Inc (PK)
0.0003
0.0001 (50.00%)
Volume: 9,309,124
Day Range: 0.0002 - 0.0003
Last Trade Time: 3:59:56 PM EST